Joseph Limber

Joseph Limber

Director/Board Member at XOMA ROYALTY CORPORATION

Net worth: 1 M $ as of 2026-05-30

72 year
Health Technology
Commercial Services
Health Services

Profile

Joseph M.
Limber
is currently Chief Executive Officer at Garda Therapeutics, Inc. and Independent Director at XOMA Royalty Corp.
Formerly, Mr. Limber was President & Chief Executive Officer at Monogram Biosciences, Inc. from 1998 to 2002; President & Chief Executive Officer at Deltagen, Inc. in 2003; President, Chief Executive Officer & Director at Genoptix, Inc. from 2017 to 2018; President & Chief Executive Officer at Gradalis, Inc. from 2013 to 2015; President, Chief Executive Officer & Director at Prometheus Laboratories, Inc. from 2004 to 2013; President, Chief Executive Officer & Director at Secura Bio, Inc.; Chairman at Molecular Insight Pharmaceuticals, Inc. in 2010; Executive Chairman at ImaginAb, Inc. from 2016 to 2017; Director at V.I.
Technologies, Inc.; Independent Non-Executive Director at CombiMatrix Corp.
in 2012; Director at Panacos Pharmaceuticals, Inc. from 2001 to 2009; Executive Vice President at SEQUUS Pharmaceuticals, Inc.; and President & Chief Operating Officer at Praecis Pharmaceuticals, Inc. from 1996 to 1998.
Education includes undergraduate studies at Duquesne University of The Holy Spirit.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-20 12,820 ( 0.1% ) 534 722 $ 2026-05-30
2026-05-20 20,000 ( 1.14% ) 506 800 $ 2026-05-30
2026-05-20 10,000 ( 1.02% ) 254 550 $ 2026-05-30

Joseph Limber active positions

CompaniesPositionStart
XOMA ROYALTY CORPORATION Director/Board Member 2012-12-12

Former positions of Joseph Limber

CompaniesPositionEnd
Chief Executive Officer 2018-11-30
Chairman 2017-10-31
Chief Executive Officer 2015-03-31
Chief Executive Officer 2013-03-31
COMBIMATRIX CORP Director/Board Member 2012-10-08
See the detail of Joseph Limber's experience

Training of Joseph Limber

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!